Bupivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on 02/20/2018.
Shortage Details
- Status
- Current
- Company
- Somerset Therapeutics, LLC
- Package NDC
- 70069-752-01
- Dosage Form
- Injection
- Presentation
- Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)
- Initial Posting
- 02/20/2018
- Revised Date